NYFSGIBN NYSE FactSet Global Genomics and Immuno Biopharma Index

The Index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.

0.00
As of 06/26/2022


Index Information
Provider:     ICE (NYSE)
Category1:  Global Equity
Category2:  Single industry
Category3:  Healthcare
Currency:    USD
Inception date:  01/01/1900
Backtesting data exists:  
Weighting methodology:   Market capitalization
Number of holdings:  48  (as of 01/20/2020)

As explained in what is an index, there is no universal system of giving an index a symbol. You can search for indexes using our index symbol lookup.

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy